Teleflex (NYSE:TFX) announced that Stephen Klasko, chair of its board of directors, will conclude his term at the company's ...
Teleflex has recently overhauled its governance, naming long-time director Andrew A. Krakauer as Chairman, adding Michael J. Tokich to the Board, forming a new Growth and Operating Committee, and ...
Shares of Teleflex Inc. TFX rallied 4.05% to $123.18 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 1.02% to 6,886.24 and the ...
Palm Valley Capital Management, an investment management firm, has issued the first-quarter 2026 investor letter for the ...
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Teleflex (NYSE:TFX) and the ...
Teleflex developments highlight sector dynamics, rating revisions, and inclusion across major US indices, reflecting its role ...
VISTA.Today on MSN
Wayne-based Teleflex pressured by activist investor to consider acquisition offers
Irenic Capital Management is pushing Wayne-based Teleflex to evaluate potential acquisition offers and replace Dr. Stephen ...
Teleflex TFX posted solid fourth-quarter performance, ending the year on a stable note. On one hand, currency was a major headwind across all segments this fiscal year, and supply chain and staffing ...
Irenic Capital Management, LP, one of the largest shareholders of Teleflex Incorporated ("Teleflex" or the "Company") (NYSE: TFX) with 2% ownership, today issued the following statement regarding the ...
Dr. Stephen Klasko to step down as Teleflex chairman shortly after activist investor Irenic Capital urged board changes at ...
Teleflex may be enjoying improved profits and sales. But it will still lay off workers and close plants as it restructures in the face of what top executive Benson F. Smith describes as "continuing ...
Teleflex stock (NYSE: TFX), best known for its single-use medical devices for common diagnostic and therapeutic procedures, has seen a 31% fall this year, underperforming the broader S&P500 index, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results